Peptides for Cardiovascular Health
Peptides studied for heart health, cardiovascular risk reduction, and vascular function.
Important
This page lists peptides that have been studied in the context of cardiovascular health research. Inclusion does not mean a peptide is safe, effective, approved, or recommended.
Do not use this page to make health decisions. Always consult a licensed healthcare provider.
14 peptides
Dulaglutide (Trulicity)
FDA ApprovedAn FDA-approved once-weekly injection (Trulicity) for type 2 diabetes that controls blood sugar and also reduces the risk of heart attack and stroke...
Liraglutide (Victoza, Saxenda)
FDA ApprovedAn FDA-approved once-daily injection that mimics a natural gut hormone to control blood sugar in type 2 diabetes (Victoza) and promote significant...
Octreotide (Sandostatin, Sandostatin LAR, Mycapssa, Bynfezia Pen)
FDA ApprovedAn FDA-approved injection (Sandostatin) that helps control the overproduction of certain hormones in the body. It is used to treat acromegaly (excess...
Oxytocin (Pitocin)
FDA ApprovedAn FDA-approved hormone injection (Pitocin) used in hospitals to start or strengthen labor contractions and to prevent excessive bleeding after...
Semaglutide (Ozempic, Wegovy, Rybelsus)
FDA ApprovedAn FDA-approved medication sold as Ozempic (for type 2 diabetes) and Wegovy (for weight management), given as a once-weekly injection or a daily oral...
Tirzepatide (Mounjaro, Zepbound)
FDA ApprovedAn FDA-approved once-weekly injection (Mounjaro for type 2 diabetes, Zepbound for weight loss) that activates two natural gut hormone pathways at...
Vasopressin (Vasostrict, Pitressin; also known as AVP, ADH)
FDA ApprovedAn FDA-approved emergency hospital medication (Vasostrict) used for dangerously low blood pressure and during cardiac arrest. It works by tightening...
CagriSema
Late-Stage ClinicalAn investigational once-weekly combination injection that pairs two appetite-controlling medications to produce powerful weight loss. In a major...
Ecnoglutide
Late-Stage ClinicalA once-weekly injection approved in China for type 2 diabetes and obesity that works by mimicking a natural gut hormone to lower blood sugar and...
Retatrutide (LY3437943)
Late-Stage ClinicalAn investigational once-weekly injection that works on three different appetite and metabolism pathways at once, producing some of the most...
Survodutide (BI 456906)
Late-Stage ClinicalAn investigational once-weekly injection being developed for obesity and MASH (a serious form of fatty liver disease that can lead to liver damage)....
GHRP-6
Early ClinicalA synthetic peptide that mimics ghrelin (the body's hunger hormone) to stimulate the natural release of growth hormone, which has been shown...
Hexarelin
Early ClinicalA synthetic peptide that produces the strongest single-dose growth hormone release of any peptide in its class, though it also raises stress hormones...
VIP (Vasoactive Intestinal Peptide); Aviptadil (synthetic VIP); ZYESAMI; RLF-100
Early ClinicalA natural peptide that relaxes blood vessels, reduces inflammation, and protects nerve cells throughout the body and brain. A synthetic version was...